BlackRock Science and Technology Term Trust EBIT

The latest EBIT for BSTZ is $590M as of December 2025. That compares with $700K in the prior-year period — up 84214.1% year over year. That is above the sector sector average of $-77M. Investors often review this figure alongside BlackRock Science and Technology Term Trust's historical trend and sector peers before judging valuation or financial health.

Over the past year, BSTZ's EBIT moved from $700K to $590M — a 84214.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BlackRock Science and Technology Term Trust's operating scale or balance-sheet position.

Against its sector companies, BSTZ currently prints $590M for EBIT, while the sector average sits near $-77M. That is roughly 873.7% above the sector mean. Large gaps often invite a closer look at BlackRock Science and Technology Term Trust's growth, margins, and balance sheet.

A EBIT figure of $590M for BSTZ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-77M. Explore the charts below for those layers of context.

After noting BSTZ's EBIT ($590M), review year-over-year change from $700K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.